Mydecine Innovations Group Inc (MYCO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47 | 0 | 10 | 0 | 60 |
| Receivables | 0 | 0 | 0 | 50 | 118 |
| TOTAL | $47 | $0 | $10 | $51 | $178 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $47 | $0 | $10 | $51 | $178 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,943 | 7,029 | 7,015 | 6,875 | 6,529 |
| Accounts payable and accrued liabilities | 2,477 | 2,305 | 2,292 | 7,058 | 10,954 |
| Accrued Expenses | 915 | 1,175 | 1,204 | 1,002 | 140 |
| TOTAL | $15,207 | $15,318 | $15,230 | $14,972 | $17,623 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $15,207 | $15,318 | $15,230 | $14,972 | $17,623 |
| Shareholders' Equity | |||||
| Common Shares | 126,269 | 126,269 | 126,269 | 126,269 | 126,269 |
| Retained earnings | -158,502 | -158,661 | -158,563 | -158,264 | -160,788 |
| Other shareholders' equity | 286 | 286 | 286 | 286 | 286 |
| TOTAL | $-15,159 | $-15,318 | $-15,220 | $-14,921 | $-17,445 |
| Total Liabilities And Equity | $47 | $0 | $10 | $51 | $178 |